3230 WPI (Meloxicam 7.5 mg)
Pill imprint 3230 WPI has been identified as Meloxicam 7.5 mg.
Meloxicam is used in the treatment of inflammatory conditions; osteoarthritis; rheumatoid arthritis; fibromyalgia; tendonitis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 3230 WPI
- 7.5 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule:
- Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
|NDC Code||Manufacturer / Repackager|
|55289-0376||PDRX Pharmaceuticals Inc (repackager)|
|10544-0320||Blenheim Pharmacal Inc (repackager)|
|66336-0099||Dispensing Solutions Inc. (repackager)|
|18837-0239||Innoviant Pharmacy Inc (repackager)|
Note: Inactive ingredients may vary.
More about meloxicam
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.